A detailed history of Catalytic Wealth Ria, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 2,984 shares of DXCM stock, worth $239,436. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,984
Previous 2,446 22.0%
Holding current value
$239,436
Previous $277 Million 27.87%
% of portfolio
0.03%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$64.0 - $116.06 $34,432 - $62,440
538 Added 22.0%
2,984 $200 Million
Q2 2024

Jul 31, 2024

SELL
$110.31 - $140.45 $31,658 - $40,309
-287 Reduced 10.5%
2,446 $277 Million
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $3,655 - $4,483
32 Added 1.18%
2,733 $379 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $203,898 - $335,356
2,701 New
2,701 $335 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.